Search by Drug Name or NDC

    NDC 70000-0132-01 Extra Strength Sinus Relief Nasal Decongestant 1 g/100mL Details

    Extra Strength Sinus Relief Nasal Decongestant 1 g/100mL

    Extra Strength Sinus Relief Nasal Decongestant is a NASAL SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by CARDINAL HEALTH. The primary component is PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 70000-0132
    Product ID 70000-0132_e57de515-a1b5-44cd-9694-b95d6ad91252
    Associated GPIs 42102050102015
    GCN Sequence Number 008062
    GCN Sequence Number Description phenylephrine HCl SPRAY 1 % NASAL
    HIC3 Q7D
    HIC3 Description NOSE PREPARATIONS, VASOCONSTRICTORS(OTC)
    GCN 34124
    HICL Sequence Number 002087
    HICL Sequence Number Description PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name Extra Strength Sinus Relief Nasal Decongestant
    Proprietary Name Suffix n/a
    Non-Proprietary Name Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SPRAY
    Route NASAL
    Active Ingredient Strength 1
    Active Ingredient Units g/100mL
    Substance Name PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name CARDINAL HEALTH
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 70000-0132-01 (70000013201)

    NDC Package Code 70000-0132-1
    Billing NDC 70000013201
    Package 1 BOTTLE, SPRAY in 1 CARTON (70000-0132-1) / 30 mL in 1 BOTTLE, SPRAY
    Marketing Start Date 2017-06-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.065
    Pricing Unit ML
    Effective Date 2022-10-19
    NDC Description SINUS RELIEF 1% NASAL SPRAY
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis